ArticleBMJ open2026

Acceptability and safety of two sequential doses of psilocybin in bipolar II depression: protocol for an open-label single-arm feasibility study.

Thomas D Meyer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.